Rahmer Peter sold $14K of RLAY
Rahmer Peter (See remarks) sold 748 shares of Relay Therapeutics, Inc. (RLAY) at $18.61 on 2026-07-28.
How this was made
The 30-second read
Why it matters
An officer open-market sale was reported, but the disclosure does not include any new company-specific performance, guidance, or regulatory/clinical catalyst.
Market read
Traders may note insider selling as a minor sentiment datapoint, but there is no actionable fundamental change in the text.
What to watch
No 10b5-1 plan is noted, but the filing also lacks context (taxes, diversification, planned expenses), limiting interpretability.
Background
The article is an SEC Form 4 insider transaction disclosure for Relay Therapeutics, Inc.
Ticker impact
Relay Therapeutics Form 4 shows officer Rahmer Peter sold 748 shares at $18.61 on 2026-07-28, totaling about $13.9K.
Likely limited near-term impact; any effect would be small and short-lived unless followed by additional disclosures.
The transaction size is small relative to a typical public-company float, and the filing provides no new operational or financial catalyst.
Market effects
No clear sector read-through from a small, routine insider sale.
None.
None.
Counterpoint
The sale may be for personal liquidity needs and does not necessarily signal reduced confidence, especially without any accompanying negative company news.
Key entities
- issuerRelay Therapeutics, Inc.
Subject of the Form 4 insider transaction disclosure.
- insiderRahmer Peter
Officer who sold 748 shares at $18.61 on 2026-07-28.